FLAG regimen: Difference between revisions

	WikiDoc Resources for FLAG regimen
Articles
Most recent articles on FLAG regimen Most cited articles on FLAG regimen Review articles on FLAG regimen Articles on FLAG regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on FLAG regimen Images of FLAG regimen Photos of FLAG regimen Podcasts & MP3s on FLAG regimen Videos on FLAG regimen
Evidence Based Medicine
Cochrane Collaboration on FLAG regimen Bandolier on FLAG regimen TRIP on FLAG regimen
Clinical Trials
Ongoing Trials on FLAG regimen at Clinical Trials.gov Trial results on FLAG regimen Clinical Trials on FLAG regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on FLAG regimen NICE Guidance on FLAG regimen NHS PRODIGY Guidance FDA on FLAG regimen CDC on FLAG regimen
Books
Books on FLAG regimen
News
FLAG regimen in the news Be alerted to news on FLAG regimen News trends on FLAG regimen
Commentary
Blogs on FLAG regimen
Definitions
Definitions of FLAG regimen
Patient Resources / Community
Patient resources on FLAG regimen Discussion groups on FLAG regimen Patient Handouts on FLAG regimen Directions to Hospitals Treating FLAG regimen Risk calculators and risk factors for FLAG regimen
Healthcare Provider Resources
Symptoms of FLAG regimen Causes & Risk Factors for FLAG regimen Diagnostic studies for FLAG regimen Treatment of FLAG regimen
Continuing Medical Education (CME)
CME Programs on FLAG regimen
International
FLAG regimen en Espanol FLAG regimen en Francais
Business
FLAG regimen in the Marketplace Patents on FLAG regimen
Experimental / Informatics
List of terms related to FLAG regimen

VisualWikitext

Latest revision as of 20:16, 17 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

FLAG regimen refers to a regimen consisting of fludarabine, high-dose cytarabine (AraC) and filgrastim (G-CSF), used as a remission-induction treatment for relapsed or refractory childhood acute myeloid leukemia (AML)^[1]

Regimen

FLFludarabine

ACytarabine (AraC)

GFilgrastim (G-CSF)

Indications

Relapsed or refractory childhood acute myeloid leukemia (AML)^[1]

References

↑ ^1.0 ^1.1 Montillo M, Mirto S, Petti MC, Latagliata R, Magrin S, Pinto A; et al. (1998). "Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia". Am J Hematol. 58 (2): 105–9. PMID 9625576.

[pmid9625576-1] 1.0 ^1.1 Montillo M, Mirto S, Petti MC, Latagliata R, Magrin S, Pinto A; et al. (1998). "Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia". Am J Hematol. 58 (2): 105–9. PMID 9625576.

[1]

@@ Line 3: / Line 3: @@
 {{CMG}}; {{AE}} {{AV}}
+==Overview==
-==Overview==
 {{PAGENAME}} refers to a regimen consisting of [[fludarabine]], high-dose [[cytarabine|cytarabine (AraC)]] and [[filgrastim]] ([[G-CSF]]), used as a remission-induction treatment for relapsed or refractory childhood [[acute myeloid leukemia]] (AML)<ref name="pmid9625576">{{cite journal| author=Montillo M, Mirto S, Petti MC, Latagliata R, Magrin S, Pinto A et al.| title=Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia. | journal=Am J Hematol | year= 1998 | volume= 58 | issue= 2 | pages= 105-9 | pmid=9625576 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9625576 }} </ref>